Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
暂无分享,去创建一个
P. Møller | E. Hovig | S. Nakken | D. Evans | G. Capellá | A. Lindblom | E. Rødland | J. Mecklin | K. Tharmaratnam | J. Burn | I. Bernstein | I. Frayling | L. Sunde | M. Mints | J. Sampson | F. Lalloo | H. Vasen | F. Macrae | G. Möslein | R. Sijmons | E. Holinski‐Feder | I. Blanco | J. Wijnen | L. Bertario | J. Plazzer | M. Navarro | M. Pineda | P. Sala | K. Pylvanainen | K. Green | T. Seppälä | Jacqueline Jeffries | W. H. de Vos Tot Nederveen Cappel | James O. Hill | M. Morak | L. Renkonen-Sinisalo | E. Holinski-Feder | L. Renkonen‐Sinisalo | J. Hill | N. Niels Cappel | D. Evans | J. Hill | D. Evans | D. Evans | D. Evans | James O. Hill | W. H. D. Vos | D. Evans
[1] Ken R. Smith,et al. Risk of Incident Colorectal Cancer and Death After Colonoscopy: A Population-based Study in Utah. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] P. Siersema,et al. Multicenter, randomized, tandem evaluation of EndoRings colonoscopy – results of the CLEVER study , 2015, Endoscopy.
[3] M. Kloor,et al. Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome – Molecular Alterations and Association with Clinical Parameters , 2015, PloS one.
[4] Aung Ko Win,et al. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] F. Lalloo,et al. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[6] P. Peltomäki,et al. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation , 2014, Epigenetics.
[7] I. Frayling,et al. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. , 2014, Health technology assessment.
[8] Randall W Burt,et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. , 2014, Diseases of the colon and rectum.
[9] B. Karlan,et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] P. Peltomäki,et al. Distinct molecular profiles in Lynch syndrome‐associated and sporadic ovarian carcinomas , 2013, International journal of cancer.
[11] P. Møller,et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.
[12] M. Woods,et al. Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation , 2012, Clinical genetics.
[13] M. Kloor,et al. Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial , 2012, British Journal of Cancer.
[14] Rodney J Scott,et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial , 2011, The Lancet.
[15] D. Evans,et al. Hyperplastic Polyps Are Innocuous Lesions in Hereditary Nonpolyposis Colorectal Cancers , 2011, International journal of surgical oncology.
[16] P. Møller,et al. CGEN—A clinical GENetics software application , 2011, Human mutation.
[17] P. Møller,et al. Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers , 2010, Journal of Medical Genetics.
[18] E. Dekker,et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. , 2010, Gastroenterology.
[19] M. Kloor,et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[20] M. Kloor,et al. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome , 2010, Familial Cancer.
[21] Jukka-Pekka Mecklin,et al. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] P. Møller,et al. Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds , 2009, Journal of Medical Genetics.
[23] Mari Mino-Kenudson,et al. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. , 2009, The Journal of molecular diagnostics : JMD.
[24] A. Godwin,et al. Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management , 2009, Molecular oncology.
[25] P. Møller,et al. Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer , 2007, Scandinavian journal of gastroenterology.
[26] P. Møller,et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. , 2004, Gastroenterology.
[27] P. Eilers,et al. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. , 2004, Gastroenterology.
[28] P. Møller,et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.